Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 26, 2023 9:28pm

160 Views

Post# 35416056

RE:RE:RE:Only 12 Evaluable Patients at 450 days 67% CR !!!!!!

Yep River,

Seems that way to me. We get 1st qtr data end of May, I think. Then the AGM happens end of June. I wonder how close TLT will be to continuing Phase 2 towards BTD and AA at those points?

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"